ERN ReCONNET accredited e-Learning Course on Rare and Complex Connective Tissue Diseases – UEMS accredited
Rare and complex connective tissue and musculoskeletal disorders often present with atypical clinical features, making diagnosis and management particularly challenging.
To address this, ERN ReCONNET offers a comprehensive accredited online training program designed to equip physicians and healthcare professionals with the specialized knowledge and skills needed to recognize and manage these conditions effectively.
Through 10 focused modules, this e-learning course enhances clinical understanding and promotes multidisciplinary coordination by combining expert insights with valuable patient perspectives—ultimately aiming to improve care quality and outcomes for individuals living with these rare and complex diseases.
Course Highlights:
- Explore the latest in diagnosis, treatment, and management of rare CTDs.
- Gain perspectives from patients living with these conditions.
- Learn from leading specialists and clinicians across Europe.
- 100% accredited online format designed for healthcare professionals and students.
Target audience:
Designed for healthcare professionals, researchers and trainees specializing in the study and treatment of rare and complex diseases of the connective tissue and musculoskeletal system.
Course organisation:
At ERN ReCONNET, we understand that healthcare professionals and students have demanding schedules.
That’s why this accredited course is offered in a flexible e-learning format, allowing participants to study whenever and wherever it suits them best.
Learners can choose which modules to complete at their own pace, with each module concluding with a multiple-choice quiz to assess their understanding. After successfully completing all modules, participants are eligible to take the final exam.
Accreditation
The ERN ReCONNET e-Learning Course on Rare and Complex Connective Tissue Diseases is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®), an institution of the European Union of Medical Specialists (UEMS).
Upon successful completion of the course, participants will be awarded 37 European CME Credits (ECMEC®) as formal recognition of their achievement. A certificate indicating the total number of ECMEC® credits earned will be provided.
Course content:
1. Antiphospholipid Syndrome: Patient experience, pathophysiology, how to test, how to manage, CAPS, hot topics (childhood-onset APS, how to navigate the ACR/EULAR 2023 APS classification
2. Ehlers-Danlos Syndromes: Patient experience, clinical presentation and differential diagnosis of non-vascular EDS, molecular confirmation, principles of treatment, including physical medicine and rehabilitation
3. IgG4-Related Diseases: Patient experience, pathophysiology, clinical aspects, red flags and diagnosis
4. Idiopathic Inflammatory Myopathies: Patient experience, pathophysiology, ILD, heart involvement in myositis, dysphagia and exercise in myositis
5. Mixed Connective Tissue Disease: Patient experience, pathophysiology, epidemiology, clinicals aspects and red flags, diagnosis, prognosis, how to treat, what targets?
6. Relapsing Polychondritis: Patient experience, pathophysiology, epidemiology, clinical aspects and red flags, diagnosis, treatment, hot topics (eyes and VEXAS)
7. Sjögren’s Disease. Patient experience, SjD in pregnancy and in childhood; hot topics (GI manifestations, lymphoma and amyloidosis)
8. Systemic Lupus Erythematosus: Patient experience, immune thrombocytopenia, late onset lupus, lung and heart involvement, LN management
9. Systemic Sclerosis: Patient experience, hot topics (oral hygiene, soft tissue damage, nutrition, calcinosis)
10. Undifferentiated Connective Tissue Disease: Discusses diagnosis, treatment, and special issues such as pregnancy and vaccination.
Registration:
Free and open to interested participants who are affiliated with one of the ERN ReCONNET Full Member centres or Affiliated Partners centers. Sign up via the registration form : Click here to register to the course
